COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,585 Articles (22,905 medRxiv, 8,680 bioRxiv)

Most recent first Previous |  Page 671: Articles 6701-6710  | Next

Clomipramine inhibits dynamin L-α-phosphatidyl-L-serine stimulated GTPase activity
Miyoshi, H., Otomo, M., Takahashi, K.
10.1101/2022.09.09.507370 — Posted: 2022-09-12
Multicentre diagnostic evaluation of OnSite COVID-19 Rapid Test (CTK Biotech) among symptomatic individuals in Brazil and The United Kingdom
Thompson, C. R., Torres, P. M., Kontogianni, K., Bengey, D., Byrne, R. L., Noguera, S. V., Luna-Muschi, A. J., Andrade, P. S., dos Santos Barboza, A., Nishikawara, M., Body, R., de Vos, M., Escadafal, C., Adams, E. R., Costa, S. F., Cubas Atienzar, A. I.
10.1101/2022.09.12.22279847 — Posted: 2022-09-12
Effects of the COVID-19 pandemic on the mental health of clinically extremely vulnerable children and children living with clinically extremely vulnerable people in Wales: A data linkage study
Cowley, L. E., Hodgson, K., Song, J., Whiffen, T., Tan, J., John, A., Bandyopadhyay, A., Davies, A. R.
10.1101/2022.09.11.22279823 — Posted: 2022-09-12
MAM: Flexible Monte-Carlo Agent-based Model for Modelling COVID-19 Spread
De-Leon, H., Aran, D.
10.1101/2022.09.11.22279815 — Posted: 2022-09-12
Targeting intracellular Neu1 for Coronavirus Infection Treatment
Yang, D., Wu, Y., Turan, I., Keil, J., Li, K., Chen, M. H., Liu, R., Wang, L., Sun, X.-L., Chen, G.
10.1101/2022.09.09.507342 — Posted: 2022-09-11
Treatment with anti-inflammatory viral serpin modulates immuno-thrombotic responses and improves outcomes in SARS-CoV-2 infected mice
Zhang, L., Li, Y. H., Kibler, K., Kraberger, S., Varsani, A., Turk, J., Elmadbouly, N., Aliskevich, E., Spaccarelli, L., Estifanos, B., Enow, J., Zanetti, I. R., Saldevar, N., Lim, E., Browder, K., Wilson, A., Juan, F. A., Pinteric, A., Garg, A., Gisriel, S., Jacobs, B., Karr, T. L., Florsheim, E. B., Kumar, V., Wallen, J., Rahman, M., McFadden, D. G., Hogue, B., Lucas, A. R.
10.1101/2022.09.09.507363 — Posted: 2022-09-11
Real-world Effectiveness of Sotrovimab for the Early Treatment of COVID-19 During SARS-CoV-2 Delta and Omicron Waves in the United States
Cheng, M. M., Reyes, C., Satram, S., Birch, H., Gibbons, D. C., Drysdale, M., Bell, C. F., Suyundikov, A., Ding, X., Maher, M. C., Yeh, W., Telenti, A., Corey, L.
10.1101/2022.09.07.22279497 — Posted: 2022-09-11
LEAF- 4L6715 enhances oxygenation in patients with acute respiratory distress syndrome (ARDS) due to severe COVID-19: Final results of a phase I/II clinical trial
Mertes, P.-M., Delabranche, X., Coliat, P., Roche, A.-C., Collange, O., Voegelin, M., Bernard, A., Dhindsa, N., Xu, H., Geng, B., Niyikiza, C., Moyo, V., Bourbon, C., Villa, P., Detappe, A., Pivot, X.
10.1101/2022.09.07.22279668 — Posted: 2022-09-10
Noninvasive diagnosis of secondary infections in COVID-19 by sequencing of plasma microbial cell-free DNA.
Lisius, G. L., Duttagupta, R., Ahmed, A., Hensley, M., Al-Yousif, N., Lu, M., Bain, W., Shah, F., Schaefer, C., Qin, S., Wang, X., Zhang, Y., Kevin, M., Hughes, E., Jacobs, J., Naqvi, A., Haidar, G., Mellors, J., Methe, B., McVerry, B., Morris, A., Kitsios, G.
10.1101/2022.09.09.22279790 — Posted: 2022-09-10
A phase 3, randomised, double-blind, placebo-controlled clinical trial for adult evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine (ABDALA-3 Study).
Hernandez-Bernal, F., Ricardo-Cobas, M. C., Martin-Bauta, Y., Rodriguez-Martinez, E., Urrutia-Perez, K., Urrutia-Perez, K., Quintana-Guerra, J., Navarro-Rodriguez, Z., Pinera-Martinez, M., Rodriguez-Reinoso, J. L., Chavez-Chong, C. O., Baladron-Castrillo, I., Melo-Suarez, G., Batista-Izquierdo, A., Pupo-Mico, A., Mora-Betancourt, R., Soler-Cano, D., Bizet-Almeida, J., Martinez-Rodriguez, M. C., Lobaina-Lambert, L., Velazquez-Perez, V. M., Soler-Diaz, J., Blanco-Garrido, Y., Laurencio-Vallina, S., Merino-Hechavarria, T., Carmenaty-Campos, N., Rodriguez-Montero, E., Limonta-Fernandez, M., Alonso-Valdes, M., Hernandez-Rodriguez, R., Pimentel Vazquez, E., Catasus-Alvarez, K. M., Cabrera-Nunez, M. V., Ayala-Avila, M., Muzio-Gonzalez, V. L.
10.1101/2022.09.08.22279690 — Posted: 2022-09-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).